F.D.A. Requires Drug Manufacturers to Change Labels and Warn of Risk of Nerve Damage for Patients taking Oral and Injectable Fluoroquinolone Drugs
Summary On August 15, 2013, the U.S. Food and Drug Administration (F.D.A.) issued a safety
NO FEE UNLESS WE WIN
FREE CASE REVIEW
800-247-1623
Summary On August 15, 2013, the U.S. Food and Drug Administration (F.D.A.) issued a safety
A DePuy Pinnacle Multi-district litigation (“MDL”) status conference was held on September 10, 2013 at
On August 21, 2013, Judge Robert L. Miller, Jr., the Judge presiding over the consolidated
The FDA issued a Safety Alert requiring all manufacturers of Fentanyl patches, brand name Duragesic,
Summary Recent events in Karnes County, Texas point to a growing concern with the effect
According to an article written by Tilman Calliess and Henning Windhagen, “Kinematic Alignment in Total
Consumer Reports published an article in September 2013 calling for medical device manufacturers to provide
On August 23, 2013, the Centers for Disease Control and Prevention (CDC) published a report
The first DePuy ASR bellwether trial was scheduled to begin on September 9th in the
There are approximately 11,500 DePuy ASR cases pending in the United States in various state
The Ontario Superior Court of Justice recently certified a class action lawsuit brought by Canadian
End-Stage Revision Knee Device Recalled DePuy Orthopaedics, Inc. recalled its LPS Diaphyseal Sleeve which is
Get a Free Consultation. No Fees Unless We Win. We’re Here 24/7